These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9169645)

  • 1. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation.
    Podestà M; Piaggio G; Frassoni F; Pitto A; Mordini N; Bregante S; Valeriani A; Bacigalupo A
    Bone Marrow Transplant; 1997 May; 19(10):1011-7. PubMed ID: 9169645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
    Mitsuyasu RT; Li SN; Champlin RE; Gale RP
    Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation.
    Bacigalupo A; Piaggio G; Podesta M; Figari O; Benvenuto F; Sogno G; Tedone E; Raffo MR; Grassia L; Ferrero R
    Bone Marrow Transplant; 1995 Feb; 15(2):221-6. PubMed ID: 7773210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonogenic assays and engraftment in allogeneic bone marrow transplantation.
    Gerhartz HH; Kolb HJ; Clemm C; Wilmanns W
    Bone Marrow Transplant; 1986 Dec; 1(2):221-6. PubMed ID: 2901871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of circulating haemopoietic progenitor cells in the early phase of haemopoietic reconstitution after autologous and allogeneic bone marrow transplantation.
    Kwong YL; Millar JL; Powles RL
    Bone Marrow Transplant; 1989 Sep; 4(5):575-8. PubMed ID: 2790335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
    Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint MT; Gualandi F; Hoffman R
    Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
    Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of the hematopoietic reservoir after immunosuppressive therapy or bone marrow transplantation in severe aplastic anemia.
    Podesta M; Piaggio G; Frassoni F; Pitto A; Zikos P; Sessarego M; Abate M; Teresa Van Lint M; Berisso G; Bacigalupo A
    Blood; 1998 Mar; 91(6):1959-65. PubMed ID: 9490678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemopoietic reconstitution after bone marrow transplantation.
    Arnold R; Schmeiser T; Heit W; Frickhofen N; Pabst G; Heimpel H; Kubanek B
    Exp Hematol; 1986 May; 14(4):271-7. PubMed ID: 2870935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of late graft failure after allogeneic bone marrow transplantation: detection of residual host cells using amplification of variable number of tandem repeats loci.
    Nakao S; Nakatsumi T; Chuhjo T; Ohtaguro M; Tsuchiya H; Niki T; Shiobara S; Mori T; Matsuda T
    Bone Marrow Transplant; 1992 Feb; 9(2):107-11. PubMed ID: 1349248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
    Tang-naitrisorana Y; Issaragrisil S; Visuthisakchai S; Suvatte V; Piankijakum A
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():291-5. PubMed ID: 8629127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.